FDA reminds facilities to transition from recalled endoscope reprocessors

The Food and Drug Administration continues to recommend that hospitals and other facilities using automated endoscope reprocessors made by Custom Ultrasonics transition to alternative methods to reprocess flexible endoscopes as soon as possible, the agency said in an update yesterday. FDA ordered Custom Ultrasonics to recall all of its automated endoscope reprocessors from health care facilities in November, citing violations that could result in an increased risk of infection. The company later submitted a recall strategy that the agency found inadequate, but has to date made no additional proposals to recall the reprocessors, FDA said.